Jianhua Liu

Dr. Jianhua Liu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2025 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
NWNa Wang
Na Wang
LDLexiu Deng
Lexiu Deng
HLHuiying Li
Huiying Li
NJNa Jia
Na Jia
XPXiaocui Peng
Xiaocui Peng
WZWei Zhang
Wei Zhang
Background: Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) represents a critical public health threat in China, characterized by the convergence of multidrug resistance and hypervirulence. The emergence of ceftazidime/avibactam (CZA) resistance further complicates clinical management. This study aimed to elucidate the molecular epidemiology, risk factors, and resistance mechanisms of CZA resistance in CR-hvKP across China, providing evidence for targeted interventions. Methods: A single-center molecular epidemiological analysis was conducted on 81 Carbapenem-resistant Klebsiella pneumoniae (CRKP) clinical isolates collected. All isolates underwent whole-genome sequencing for MultiLocus Sequence Typing, capsule typing, and identification of resistance genes ( bla KPC-2 and blaNDM-1 ) and virulence factors ( iucA , iroB , rmpA , rmpA 2, and peg- 344). CZA resistance mechanisms were investigated through broth microdilution minimum inhibitory concentration (MIC) testing and bioinformatics analysis. Galleria mellonella infection models were employed to assess virulence potential. Risk factors were analyzed using multivariate regression of clinical variables. Phylogenetic reconstruction employed single-nucleotide polymorphism-based analysis. Results: ST11 accounted for 96.15% (50/52) of CR-hvKP isolates, with K64 being the predominant capsule type (92.31%, 48/52). Additionally, 98.77% (80/81) of CRKP carried ≥1 virulence gene; 64.2% (52/81) of isolates with all five virulence genes exhibited lethality. Galleria mellonella revealed that the survival rate of CR-hvKP was lower than that of carbapenem-resistant non-hypervirulent Klebsiella pneumoniae (p128 mg/L) without compromising carbapenem resistance, facilitated by a unique genetic context (TnpR_Tn3-ISKpn27- bla KPC-2-ISKpn6). Conclusion: China faces a rapid dissemination of ST11 CR-hvKP clones carrying diversified CZA resistance mechanisms. The convergence of hypervirulence and resistance in ST11 lineages—accelerated by invasive procedures and international transmission—demands enhanced genomic surveillance. CZA resistance arises through multiple pathways, necessitating combination therapies and stewardship programs limiting prolonged CZA use. Our findings underscore an urgent need for rapid diagnostics targeting emergent resistance determinants and infection control measures to contain high-risk clones.

14 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LZLiqing Zheng
Liqing Zheng
LSLixia Shen
Lixia Shen
ZLZe Li
Ze Li
XZXiaoli Zhang
Xiaoli Zhang
MWMiaomiao Wu
Miaomiao Wu
JLJianhua Liu
Jianhua Liu
Osthol (osthole), known as a neuroprotective drug, has shown potent anticancer activity. However, the potential clinical application of osthol is limited due to its low water solubility and low bioavailability. Polybutyl cyanoacrylate (PBCA) has been widely used to improve the solubility of drugs with poor water solubility. In this study, an orthogonal experimental design (OED) was applied to design the preparation process of PBCA nanoparticles (NPs). Then, nanoparticles were prepared and evaluated in terms of physicochemical properties, in vitro release, and cellular uptake, etc. Further, the anti-cancer activity of osthol-PBCA NPs was demonstrated in SH-SY5Y cells. The pharmacokinetics and area under the curve (AUC) were investigated. The obtained osthol-NPs presented a spherical shape with a particle size of 110 ± 6.7 nm, a polydispersity index (PDI) of 0.126, and a zeta potential of −13 ± 0.32 mV. Compared with the free osthol, the drugs in osthol-NPs presented better stability and sustained release pattern activity. In vitro analysis using SH-SY5Y neuroblastoma cells showed that osthol-loaded nanoparticles displayed a significantly enhanced intracellular absorption process (three times) and cytotoxicity compared with free osthol (p < 0.05, increased 10–20%). The in vivo pharmacokinetic study revealed that the AUC of osthol-NPs was 3.3-fold higher than that of free osthol. In conclusion, osthol-PBCA NPs can enhance the bioactivity of osthol, being proposed as a novel, promising vehicle for drug delivery.

10 August 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
LZLiqing Zheng
Liqing Zheng
ZLZe Li
Ze Li
ZWZhao Wang
Zhao Wang
LSLixia Shen
Lixia Shen
JLJianhua Liu
Jianhua Liu

19 August 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JZJiawei Zhang
Jiawei Zhang
YLYanan Liu
Yanan Liu
YWYaru Wang
Yaru Wang
WZWei Zhang
Wei Zhang
JLJianhua Liu
Jianhua Liu
ZZZhihua Zhang
Zhihua Zhang
Background: Klebsiella pneumoniae is a critical opportunistic pathogen, with carbapenem-resistant K. pneumoniae and hypervirulent K. pneumoniae posing severe threats to global public health due to escalating antimicrobial resistance. As natural bacterial predators, phages represent a highly promising alternative to conventional antibiotics. The aim of this study was to systematically evaluate the research landscape, collaborative networks, and evolutionary trends of phage applications against Klebsiella pneumoniae infections through bibliometric analysis. Methods: Core bibliographic data were retrieved from the Web of Science Core Collection, Scopus, and PubMed databases. Following rigorous literature screening based on predefined inclusion and exclusion criteria, mainstream bibliometric analysis tools, including VOSviewer and CiteSpace, were comprehensively deployed to map and analyze the temporal dynamics of publication outputs, international collaboration networks among countries, institutions, authors, and journals, reference co-citation matrices, and keyword co-occurrence configurations, alongside timeline visualizations and citation burst detection, thereby systematically delineating the evolutionary blueprint of this research domain. Results: A total of 1,275 valid original publications were ultimately enrolled. Chronologically, the global annual publication volume exhibited a pronounced exponential growth trajectory ( y = 3.4589⋅ e 0.2381( x −2007) , R 2 = 0.9706). Geographically and structurally, China ranked first globally in research productivity with 242 documents (18.98%), the Chinese Academy of Sciences (49 documents) and investigator Jianqiang Li (30 documents) were identified as the most prolific institution and core author, respectively. Regarding publishing channels, Frontiers in Microbiology dominated in both publication scale (55 documents) and network integration density (TLS = 237). Research hotspot evolution indicated a profound paradigm shift, where contemporary citation bursts are significantly dominated by “phage resistance” (strength = 3.34) and “lytic activity” (strength = 2.77), with both frontiers remaining actively sustained into 2026. Conclusion: Over the past two decades, research has expanded exponentially, with the knowledge architecture transitioning from descriptive biological characterization to deep genetic mechanisms and engineering-driven design. Future efforts should prioritize elucidating the molecular mechanisms of phage resistance, optimizing lytic enzyme efficacy, and accelerating multicenter translational interventions to combat multi-drug resistant K. pneumoniae .

10 September 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
NWNa Wang
Na Wang
XPXiaocui Peng
Xiaocui Peng
HLHuiying Li
Huiying Li
XLXiaoyu Li
Xiaoyu Li
CLChunmei Lei
Chunmei Lei
WZWei Zhang
Wei Zhang
Background: The global rise in hypervirulent carbapenem-resistant Klebsiella pneumoniae (hv-CRKP) poses a severe threat to public health. However, the evolutionary mechanisms underlying hypervirulence in carbapenem-resistant strains remain incompletely understood. Here, we investigated the genetic basis of hypervirulence in a prevalent carbapenem-resistant lineage. Methods: Whole-genome sequencing and comparative genomic analyses were performed on 112 locally collected carbapenem-resistant Klebsiella pneumoniae (CRKP) clinical isolates collected from 2020 to 2022 and 4,636 publicly available K. pneumoniae genomes, including 557 hv-CRKP. Results: Among 66 hv-CRKP identified locally, the ST11-KL64 lineage was dominant, accounting for 87.9%. As against the classical fusion-plasmid model, these isolates harbored candidate chromosomal virulence-locus configurations, supported by convergent short-read sequencing evidence, with insertion sequences identified at or near the inferred breakpoint regions. IS-positive hv-CRKP isolates included in the phenotypic comparison showed significantly greater virulence in Galleria mellonella infection models than the IS-negative hv-CRKP comparator isolates (log-rank test, p < 0.0001). Global phylogenetic analysis showed that strains carrying related candidate chromosomal virulence-locus configurations clustered within a distinct lineage, with the currently available genomes in this group predominantly originating from China. Conclusion: This study identified recurrent candidate chromosome-associated virulence-locus configurations in ST11 hv-CRKP that are distinct from canonical fusion-plasmid architectures. This evidence extends the current models beyond plasmid fusion and underscores the value of genomic surveillance strategies capable of detecting chromosomal virulence, which may be overlooked when surveillance focuses solely on virulence plasmids. Defining this evolutionary trajectory provides a foundation for infection prevention and control, as well as for designing targeted interventions to limit the spread of these high-risk pathogens. Using multiple lines of genomic evidence, we established a framework for assessing candidate chromosomal localizations and identifying breakpoint-associated read signatures.